Krilogy Financial’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-124,477
Closed -$3.12M 399
2022
Q3
$3.12M Buy
124,477
+864
+0.7% +$21.6K 0.37% 47
2022
Q2
$3.09M Buy
123,613
+34,514
+39% +$863K 0.36% 50
2022
Q1
$2.23M Buy
+89,099
New +$2.23M 0.23% 61
2021
Q2
Sell
-20,084
Closed -$511K 281
2021
Q1
$511K Sell
20,084
-83,048
-81% -$2.12M 0.05% 172
2020
Q4
$2.64M Buy
103,132
+872
+0.9% +$22.3K 0.32% 55
2020
Q3
$2.62M Sell
102,260
-21,360
-17% -$548K 0.36% 43
2020
Q2
$3.17M Buy
123,620
+59,240
+92% +$1.5M 0.49% 36
2020
Q1
$1.6M Sell
64,380
-54,027
-46% -$1.36M 0.3% 53
2019
Q4
$3M Sell
118,407
-1,017
-0.9% -$25.7K 0.49% 45
2019
Q3
$3.02M Buy
119,424
+3,548
+3% +$89.6K 0.55% 40
2019
Q2
$2.92M Buy
115,876
+12,252
+12% +$306K 0.56% 37
2019
Q1
$2.58M Buy
+103,624
New +$2.55M 0.55% 37

Other funds holding IBDN

Krilogy Financial's IBDN Position: Q4 2022 in Review

Krilogy Financial sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 124,477 shares — an estimated $3.12M sold.

Krilogy Financial first reported a position in IBDN in Q1 2019 and held it in 12 quarters. The position peaked at $3.17M in Q2 2020. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Krilogy Financial reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Krilogy Financial sold 124,477 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $3.12M.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q1 2019 and held it in 12 quarters.
  • Krilogy Financial's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $3.17M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Krilogy Financial's 13F filing for Q4 2022, filed 13 Feb 2023.